HSDT - Helius Medical Technologies, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
33.35M
Enterprise Value 3
24.81M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
18.30
Price/Book (mrq)
3.75
Enterprise Value/Revenue 3
13.62
Enterprise Value/EBITDA 6
-1.05

Trading Information

Stock Price History

Beta (5Y Monthly) -0.21
52-Week Change 3-80.08%
S&P500 52-Week Change 325.78%
52 Week High 37.8500
52 Week Low 30.2800
50-Day Moving Average 30.8523
200-Day Moving Average 31.4372

Share Statistics

Avg Vol (3 month) 3614.94k
Avg Vol (10 day) 3723.55k
Shares Outstanding 525.9M
Float 19.76M
% Held by Insiders 122.81%
% Held by Institutions 110.91%
Shares Short (Dec 30, 2019) 42.49M
Short Ratio (Dec 30, 2019) 42.03
Short % of Float (Dec 30, 2019) 412.26%
Short % of Shares Outstanding (Dec 30, 2019) 49.59%
Shares Short (prior month Nov 28, 2019) 4679.66k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Jan 22, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,297.09%

Management Effectiveness

Return on Assets (ttm)-112.79%
Return on Equity (ttm)-438.26%

Income Statement

Revenue (ttm)1.82M
Revenue Per Share (ttm)0.07
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)478k
EBITDA -23.52M
Net Income Avi to Common (ttm)-9.56M
Diluted EPS (ttm)-0.3750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.02M
Total Cash Per Share (mrq)0.35
Total Debt (mrq)675k
Total Debt/Equity (mrq)7.65
Current Ratio (mrq)3.16
Book Value Per Share (mrq)0.34

Cash Flow Statement

Operating Cash Flow (ttm)-21.61M
Levered Free Cash Flow (ttm)-27.01M